July 2017: Strategy Report

Strategy for July 2017. Generally stocks are overvalued so my warchest is growing every month. Nevertheless, it is risky to time the market so regular DCA should still be done. 

CDLHT rights issue. $10k worth of rights to be subscribed to.

Comfort Delgro: Accumulated downwards from $2.30 to $2.24

GlaxoSmithKline: Accumulated more on dip. Global stock, not concerned about Brexit.

VOD: Small amount added.

RoyalMail: I also find it tempting to buy stocks that have been hit hard. RMG does have a decent core business and I doubt the share price will go to zero. Still, the risk is there but the dividends look good even if cut.

WPP: Initiated position: International revenue/ large cap stock / price down by more than 20% due to negative forward outlook / good dividends and dividend coverage / good forward P/E.